California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make ...

The typical Indian namkeen has become a default comfort food across age groups. However, what may seem like harmless grazing ...

Civica will begin selling a type of insulin on Jan. 1, 2026, although it will not come from the nonprofit drug maker’s Petersburg facility.

The sale of insulin is part of the state’s CalRx initiative aimed at lowering prescription drug prices for Californians.

At its core, diabetes is a disease that occurs when your blood glucose, also called blood sugar, is too high. Glucose is our ...

California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.

Long-acting insulin pens will be available at pharmacies for $11 per pen — or $55 for a five-pack — beginning Jan. 1.

Californians will be able to purchase an insulin pen for $11 under the state-run drug label, CalRx, bypassing pharmaceutical ...

Gov. Gavin Newsom said Thursday that California will begin selling affordable insulin under its own label on Jan. 1, nearly ...

Gov. Gavin Newsom announced Thursday that the state would provide insulin shots for $11, far below market prices.

Orforglipron, a novel oral GLP-1, was superior to dapagliflozin for reducing HbA1c in adults with type 2 diabetes ...

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.